LSE : 0AAJ.L

PolyPeptide Group AG

$43.81762 CHF

$0.02 (0.04%)

Volume
50.47K
Average Volume
11.09K
Market Capitalization
$1.45B
P/E Ratio
-73.46
Dividend Yield
0.00%
Price Target
Year High
$43.95
Year Low
$14.19
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.74
Company Overview

LSE

Juan Jose Gonzalez

Drug Manufacturers - Specialty & Generic

Healthcare

0AAJ.L

1362

CH

CHF

https://www.polypeptide.com

41 41 723 20 34

N/A

N/A

Liquidity Metrics

0.38

1.74

0.91

0.40

0.00

Sales & Valuation

$391.87M

3.98

4.56

-51.21

-0.92

Profitability

-$0.64

-$21.31M

-5.43%

-5.14%

-6.30%

-2.56%

P/E Metrics

-73.46

1.09

1.09

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Financial Health Scores

3.22

3/9

$138.23M

$825.31M

$484.98M

$649.42K

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Inas Khedher Head of Operations Controlling of Global Finance
Krister Svard Chief Information Security Officer & Global IT Services VC
Stéphane Varray Chief Commercial Officer
Rebecca Weil Head of Internal Audit
Andreas Liese Corporate Compliance Manager
Monika Casanova Chief Human Resources Officer
Juan Jose Gonzalez Chief Executive Officer
Michael Staheli Head of Investor Relations & Corporate Communications
Olivier Ludemann-Hombourger Director of Global Innovation & Technology
Christophe Chevalier Head of Technical Department - Braine
Trishul Shah Interim Director Global Sales & Marketing
Tim Brandl Interim CFO and Director of Investor Relations, Financial Planning & Analysis
Christina Del Vecchio Chief Legal Officer & Corporate Secretary
Rene Vestergaard Director of Corporate Finance
Poll Results

No votes yet today — be the first to share your view!

About PolyPeptide Group AG (LSE:0AAJ.L) Stock

Operating globally, PolyPeptide Group AG functions as a prominent contract development and manufacturing organization (CDMO). The company specializes in producing both proprietary and generic GMP-certified peptides, which are supplied to pharmaceutical and biotechnology firms. These crucial components are integrated into approved pharmaceutical products, drugs in various stages of clinical development, and generic medications. PolyPeptide Group also handles the manufacturing of bespoke research-grade peptides and is engaged in the development of neoantigen peptides designed to advance personalized cancer therapies. Its services further encompass the production of peptides for commercially available peptide therapeutics, as well as the creation of peptide-based generics for both human and a ... nimal health sectors, alongside peptides for the cosmetics industry. Additionally, the company offers vital regulatory affairs assistance. Established in 1952, PolyPeptide Group AG maintains its corporate headquarters in Zug, Switzerland, and operates as a subsidiary of Draupnir Holding B.V.

Frequently Asked Questions

What is the current PolyPeptide Group AG (0AAJ.L) stock price?

PolyPeptide Group AG(LSE:0AAJ.L) stock price is $43.81762 in the last trading session. During the trading session, 0AAJ.L stock reached the peak price of $43.95 while $14.18979 was the lowest point it dropped to. The percentage change in 0AAJ.L stock occurred in the recent session was 0.04% while the dollar amount for the price change in 0AAJ.L stock was $0.02.

0AAJ.L's industry and sector of operation?

The LSE listed 0AAJ.L is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of 0AAJ.L?

Inas Khedher | Head of Operations Controlling of Global Finance
Krister Svard | Chief Information Security Officer & Global IT Services VC
Stéphane Varray | Chief Commercial Officer
Rebecca Weil | Head of Internal Audit
Andreas Liese | Corporate Compliance Manager

How many employees does 0AAJ.L have?

Number of 0AAJ.L employees currently stands at 1362. 0AAJ.L operates from Neuhofstrasse 24, Baar, ZG 6300, CH.

Link for 0AAJ.L official website?

Official Website of 0AAJ.L is: https://www.polypeptide.com

How do I contact 0AAJ.L?

0AAJ.L could be contacted at phone #41 41 723 20 34 and can also be accessed through its website. 0AAJ.L operates from Neuhofstrasse 24, Baar, ZG 6300, CH.

How many shares of 0AAJ.L are traded daily?

The average number of 0AAJ.L shares traded daily for last 3 months was 11.09K.

What is the market cap of 0AAJ.L currently?

The market value of 0AAJ.L currently stands at $1.45B with its latest stock price at $43.81762